pharmaphorum

AUGUST 25, 2022

Johnson & Johnson has its first worldwide regulatory approval – in the EU – for Tecvayli, one of two much-anticipated bispecific antibodies the drugmaker has developed for patients with multiple myeloma. Tecvayli previously scored a priority medicines (PRiME) designation from the EMA and a breakthrough-therapy tag from the FDA.

FDA 93

FDA Marketing Safety Patients 93

pharmaphorum

AUGUST 21, 2022

That status goes to Johnson & Johnson’s Spravato (esketamine), which was approved in March 2019 and is administered as a nasal spray twice a week for four weeks. Auvelity isn’t the first NMDA-targeting antidepressant to reach the market.

FDA 88

FDA Marketing Pharma Sales 88

pharmaphorum

NOVEMBER 24, 2022

Johnson & Johnson’s Spravato therapy for treatment-resistant depression (TRD) hasn’t made the impact the company hoped for in the market, and it is looking to new clinical results to accelerate its take-up.

Sales 52

Sales Patients Competition Marketing 52

Contrarian Sales Techniques

JANUARY 12, 2024

Johnson gripped the steering wheel like a white-knuckled life raft, eyes wide as saucers as we navigated the dealership's obstacle course. 'Is I chuckled, calming his nerves with a reassuring, 'Just testing the suspension, Mr. I chuckled, calming his nerves with a reassuring, 'Just testing the suspension, Mr. Johnson.

Sales 52

Sales 52

pharmaphorum

JULY 25, 2022

The EMA’s human medicines committee has recommended approval of Johnson & Johnson’s Tecvayli as a fourth-line therapy for multiple myeloma , joining a growing group of BCMA-targeted therapies for the blood cancer.

Medicine 52

Medicine FDA Recruitment Patients 52

Pharmaceutical Technology

MAY 15, 2023

Innovation S-curve for the pharmaceutical industry Peptide nano-particle conjugates is a key innovation area in the pharmaceutical industry By tagging peptides with nanoparticles, peptide nano-particle conjugates allow enhanced control over their biological behaviour, overcoming intrinsic limitations of the individual materials.

Pharmaceutical 52

Pharmaceutical Leads Biopharma Medicine 52

Contrarian Sales Techniques

DECEMBER 31, 2023

Embrace the Power of Observation : Remember that time Mrs. Johnson spent hours gushing about her sourdough starter? Ditch the Clichés, Embrace the Quirky : A personalized bobblehead that captures Mrs. Johnson's penchant for salsa dancing? or a weekend getaway to Mrs. Johnson's hidden travel bucket list destination.

Sales Strategy 59

Sales Strategy Leads Specialization Sales 59